Protection of axotomized ganglion cells by salicylic acid

Brain Research

Volumn 840, Issue 1-2, 1999, Pages 162-166

  Castagné, Vincent ^a   Barnéoud, Pascal ^b   Clarke, Peter G H ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b SANOFI   (France)

Author keywords

Antioxidant; Chick embryo; Neuronal death; Redox status; Retina; Salicylic acid

Indexed keywords

SALICYLIC ACID;

ANIMAL CELL; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; INTRAOCULAR DRUG ADMINISTRATION; NERVE CELL NECROSIS; NERVE FIBER TRANSECTION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RETINA; RETINA GANGLION CELL;

ANIMALS; ANTIOXIDANTS; AXOTOMY; CHICK EMBRYO; DOSE-RESPONSE RELATIONSHIP, DRUG; NEUROPROTECTIVE AGENTS; RETINAL GANGLION CELLS; SALICYLIC ACID;

EID: 0344631605     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01788-6     Document Type: Article

References (47)

1. Al-Abdulla N.A., Martin L.J. Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am. J. Pathol. 153:1998;447-456.
2. Aubin N., Curet O., Deffois A., Carter C. Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice. J. Neurochem. 71:1998;1635-1642.
3. Barnéoud P., Curet O. Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin, on motor performance in a transgenic model of amyotrophic lateral sclerosis. Exp. Neurol. 155:1999;243-251.
4. Betts W.H., Whitehouse M.W., Cleland L.G., Vernon-Roberts B. In vitro antioxidant properties of potential biotransformation products of salicylate, sulphasalazine and amidopyrine. J. Free Radicals Biol. Med. 1:1985;273-280.
5. Burek M.J., Oppenheim R.W. Programmed cell death in the developing nervous system. Brain Pathol. 6:1996;427-446.
6. Castagné V., Clarke P.G.H. Axotomy-induced retinal ganglion cell death in development: its timecourse and its diminution by antioxidants. Proc. R. Soc. London. 263:1996;1193-1197.
7. Castagné V., Clarke P.G.H. Inhibition of glutathione synthesis can enhance cycloheximide-induced protection of developing neurons against axotomy. Dev. Brain Res. 102:1997;285-290.
8. Castagné V., Clarke P.G.H. Cooperation between glutathione depletion and protein synthesis inhibition against naturally occurring neuronal death. Neuroscience. 86:1998;895-902.
9. V. Castagné, M. Gautschi, K. Lefèvre, A. Posada, P.G.H. Clarke, Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system, Prog. Neurobiol. (1999) in press.
10. V. Castagné, K. Lefèvre, R. Natero, D.A. Becker, P.G.H. Clarke, An optimal redox status for the survival of axotomized ganglion cells in the developing retina, Neuroscience (1999) in press.
11. Catsicas S., Clarke P.G.H. Abrupt loss of dependence of retinopetal neurons on their target cells, as shown by intraocular injections of kainate in chick embryos. J. Comp. Neurol. 262:1987;523-534.
12. Clarke P.G.H. Neuronal death during development in the isthmo-optic nucleus of the chick: sustaining role of afferents from the tectum. J. Comp. Neurol. 234:1985;365-379.
13. Cui Q., Harvey A.R. At least two mechanisms are involved in the death of retinal ganglion cells following target ablation in neonatal rats. J. Neurosci. 15:1995;8143-8155.
14. Flohé L., Brigelius-Flohé R., Saliou C., Traber M.G., Packer L. Redox regulation of NF-kappa B activation. Free Radicals Biol. Med. 22:1997;1115-1126.
15. Frantz B., O'Neill E.A. The effect of sodium salicylate and aspirin on NF-kappa B. Science. 270:1995;2017-2019.
16. Globus M.Y.T., Busto R., Lin B.W., Schnippering H., Ginsberg M.D. Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J. Neurochem. 65:1995;1250-1256.
17. Greenlund L.J.S., Deckwerth T.L., Johnson E.M. Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
18. Grilli M., Memo M. Nuclear factor-kappa B/Rel proteins - a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol. 57:1999;1-7.
19. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kB activation. Science. 274:1996;1383-1385.
20. Hall E.D., Smith S.L., Oostveen J.A. Inhibition of lipid peroxidation attenuates axotomy-induced apoptotic degeneration of facial motor neurons in neonatal rats. J. Neurosci. Res. 44:1996;293-299.
21. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
22. Heiduschka P., Thanos S. NO production during neuronal cell death can be directly assessed by a chemical reaction in vivo. NeuroReport. 9:1998;4051-4057.
23. Hughes W.F., LaVelle A. The effects of early tectal lesions on development in the retinal ganglion cell layer of chick embryos. J. Comp. Neurol. 163:1975;265-283.
24. Hughes W.F., McLoon S.C. Ganglion cell death during normal retinal development in the chick: comparisons with cell death induced by early target field destruction. Exp. Neurol. 66:1979;587-601.
25. L.J. Ignarro, Nitric oxide as a communication signal in vascular and neuronal cells. In: J. Lancaster, Jr. (Ed.), Nitric Oxide, Principles and Actions, Academic Press, San Diego, 1996, pp. 111-137.
26. Klöcker N., Cellerino A., Bähr M. Free radical scavenging and inhibition of nitric oxide synthase potentiates the neurotrophic effects of brain-derived neurotrophic factor on axotomized retinal ganglion cells in vivo. J. Neurosci. 18:1998;1038-1046.
27. 2+-mediated activation of c-Jun N-terminal kinase and nuclear factor-kB by NMDA in cortical cell cultures. J. Neurochem. 71:1998;1390-1395.
28. Koliatsos V.E., Price D.L. Axotomy as an experimental model of neuronal injury and cell death. Brain Pathol. 6:1996;447-465.
29. Kopp E., Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 265:1994;956-959.
30. Kuhn W., Müller T., Büttner T., Gerlach M. Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia. Stroke. 26:1995;1959-1960.
31. Kwon G., Hill J.R., Corbett J.A., McDaniel M.L. Effects of aspirin on nitric oxide formation and de novo protein synthesis by RINm5F cells and rat islets. Mol. Pharmacol. 52:1997;398-405.
32. Layer P.G., Vollmer G. Lucifer yellow stains displaced amacrine cells of the chicken retina during embryonic development. Neurosci. Lett. 31:1982;99-104.
33. Levin L.A., Clark J.A., Johns L.K. Effect of lipid peroxidation inhibition on retinal ganglion cell death. Invest. Ophthalmol. Visual Sci. 37:1996;2744-2749.
34. Martin D.P., Ito A., Horigome K., Lampe P.A., Johnson E.M. Jr. Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons. J. Neurobiol. 23:1992;1205-1220.
35. Maynard K.I., Arango P.M., Chen D., Ogilvy C.S. Acetylsalicylate administered during simulated ischemia reduces the recovery of neuronal function in the in vitro rabbit retina. Neurosci. Lett. 249:1998;159-162.
36. McCabe D.R., Maher T.J., Acworth I.N. Improved method for the estimation of hydroxyl free radical levels in vivo based on liquid chromatography with electrochemical detection. J. Chromatogr., B: Biomed. Sci. Appl. 691:1997;23-32.
37. +. J. Neural Transm.: Gen. Sect. 89:1992;139-145.
38. Oppenheim R.W. Related mechanisms of action of growth factors and antioxidants in apoptosis: an overview. Adv. Neurol. 72:1997;69-78.
39. Riccioppo Neto F. Further studies on the actions of salicylates on nerve membranes. Eur. J. Pharmacol. 68:1980;155-162.
40. Riepe M.W., Kasischke K., Raupach A. Acetylsalicylic acid increases tolerance against hypoxic and chemical hypoxia. Stroke. 28:1997;2006-2011.
41. Schreck R., Baeuerle P.A. Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kB. Methods in Enzymology. 234:1994;151-163.
42. Schulz J.B., Weller M., Klockgether T. Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J. Neurosci. 16:1996;4696-4706.
43. Schwenger P., Bellosta P., Vietor I., Basilico C., Skolnik E.Y., Vilcek J. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2869-2873.
44. Snow R.L., Robson J.A. Ganglion cell neurogenesis, migration and early differentiation in the chick retina. Neuroscience. 58:1994;399-409.
45. Subbegowda R., Frommel T.O. Aspirin toxicity for human colonic tumor cells results from necrosis and is accompanied by cell cycle arrest. Cancer Res. 58:1998;2772-2776.
46. Wu K.K.Y. Biochemical pharmacology of nonsteroidal anti-inflammatory drugs. Biochem. Pharmacol. 55:1998;543-547.
47. V. Castagné, P.G.H. Clarke, Inhibitors of mitogen-activated protein kinases protect axotomized developing neurons, Brain Res. (1999) in press.